Postmarket Surveillance Study Confirms Benefits Cook Medical’s Zilver® PTX® Drug Eluting Stent At 12 Months In Japanese Patients

LAS VEGAS--(BUSINESS WIRE)--One-year post-market surveillance (PMS) study data from Japanese patients who received the Zilver® PTX® drug-eluting stent confirmed the benefits of the device at 12 months, researchers announced today. Japanese researchers presented the PMS study results at the Vascular Interventional Advances 2014 meeting in Las Vegas. This was the first time the study has been presented in the United States.

Help employers find you! Check out all the jobs and post your resume.